BSE filing, NSE: 5PAISA. Summary written from the filing by ALFA Finder's alert engine.
5Paisa Capital Ltd: key numbers
- Share price
- ₹339.00
- Market cap
- ₹1,589 Cr
- Revenue (annual)
- ₹319.6 Cr
- Net profit (annual)
- ₹44.18 Cr
- P/E (TTM)
- 38.0×Sector 19.7×
- Promoter holding
- 36.50%+0.00% QoQ
- FII holding
- 15.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from 5Paisa Capital Ltd
All →5Paisa Capital Other Announcement
5paisa Capital Limited submitted its Monitoring Agency Report for the quarter ended September 30, 2026. The report confirms full utilization of the Rs. 468.82 Crore rights issue proceeds.
- Value
- ₹468.8 Cr
5Paisa Capital Debt & Borrowing: ₹25 Cr
5paisa Capital Limited has fully redeemed Commercial Papers amounting to ₹25 Crore upon maturity on October 09, 2026.
- Value
- ₹25.00 Cr
5Paisa Capital Capital Structure Change
5paisa Capital Limited has submitted updated shareholding disclosures as part of the regulatory process for its previously approved preferential issue of equity shares.
5Paisa Capital Other Announcement
5paisa Capital Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
5Paisa Capital Legal & Regulatory
5paisa Capital Limited received a Show Cause cum Demand Notice from GST authorities for Rs. 15.31 Crore, alleging excess Input Tax Credit availment.
- Value
- ₹15.31 Cr
- From
- Office of the Principal Commissioner of CGST & C. Excise, Mumbai East
5Paisa Capital Management Change
Mr. Ameya Agnihotri has resigned as Whole-Time Director and Chief Technology Officer of 5paisa Capital Limited, effective from the close of business on September 30, 2026.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.